STUDY OF 12 WEEKS, RANDOMIZED, CONTROLLED WITH PLACEBO AND ACTIVE COMPARATOR, OF PARALLEL GROUP, DOUBLE BLIND, TO EVALUATE THE SAFETY AND EFFICACY OF 30 MG. OF ETORICOXIB COMPARED WITH 2400 MG OF IBUPROPHENE IN PATIENTS WITH OSTEOARTHRITIS (STUDY 2)

MERCK SHARP & DOHME PERU S.R.L.,0 个研究点目标入组 0 人开始时间: 2003年4月11日最近更新: 2023年9月4日

适应症

试验速览

暂无简介。

•The diagnosis of OA of the knee or hip was confirmed by the criteria of clinical and radiographic admission. Patients also had to demonstrate a clinical response to regular use of either NSAIDs or acetaminophen / paracetamol. The NSAID users had to show a worsening of their OA symptoms, as specified by the exacerbation criteria, after the period of pharmacological rest. Patients previously treated with acetaminophen / paracetamol, but without NSAIDs had to demonstrate a specific level of symptoms in the selection and randomization.

•The diagnosis of OA of the knee or hip was confirmed by the criteria of clinical and radiographic admission. Patients also had to demonstrate a clinical response to regular use of either NSAIDs or acetaminophen / paracetamol. The NSAID users had to show a worsening of their OA symptoms, as specified by the exacerbation criteria, after the period of pharmacological rest. Patients previously treated with acetaminophen / paracetamol, but without NSAIDs had to demonstrate a specific level of symptoms in the selection and randomization.

发起方

MERCK SHARP & DOHME PERU S.R.L.,